Evidence map›Paper›PMID 40731371›Full record

ArticleImplementation science communications2025

Characterizing screening champions in the center for disease control and prevention's Colorectal Cancer Control Program (CRCCP).

Cam Escoffery, Juzhong Sun, Amy DeGroff, Krishna Sharma, Manal Masud, Thuy Vu, Dara Schlueter, Peggy Hannon

Abstract read
In one paragraph

Article in Implementation science communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Cam EscofferyDepartment of Behavioral, Social and Health Education Sciences, Rollins School of Public Health, 1518 Clifton Road5 Floor, Atlanta, NE, GA, 30322, United States. cescoff@emory.edu.ORCID http://orcid.org/0000-0003-4445-009X
Juzhong SunTJFACT LLC, Atlanta, GA, United States.
Amy DeGroffCenters for Disease Control and Prevention, Atlanta, GA, United States.
Krishna SharmaTJFACT LLC, Atlanta, GA, United States.
Manal MasudHealth Promotion Research Center, University of Washington School of Public Health, Seattle, WA, United States.
Thuy VuHealth Promotion Research Center, University of Washington School of Public Health, Seattle, WA, United States.
Dara SchlueterCenters for Disease Control and Prevention, Atlanta, GA, United States.
Peggy HannonHealth Promotion Research Center, University of Washington School of Public Health, Seattle, WA, United States.

Funding

CDC HHS U48DP001934CDC HHS U48DP005013CDC HHS U48 DP006398NCCDPHP CDC HHS U48 DP001934NCCDPHP CDC HHS U48 DP005013NCCDPHP CDC HHS U48 DP006377NCCDPHP CDC HHS U48 DP006398NCCDPHP CDC HHS U48 DP006841
6 · The paper itself

Abstract

backgroundCDC's Colorectal Cancer Control Program (CRCCP) aims to increase colorectal cancer (CRC) screening prevalence by implementing evidence-based interventions (EBIs) in health system clinics partnering with the program. Program champions, as one of the key program components, are expected to facilitate the implementation of EBIs and support desired changes in many ways. Given limited information about the champions in clinical systems, this study investigated champion types, roles, and sustainability within the CRCCP.

methodsThis mixed methods, cross-sectional study included a survey of 205 respondents (health system and clinic staff) representing 303 clinics and 12 qualitative interviews of CRCCP award recipients and partnering clinics. The survey assessed clinic characteristics, EBI implementation, information about program champions, and sustainability. Interview topics included champion roles, benefits, turnover, and maintenance.

findingsChampions worked at either the health system or clinic level. Among health systems, champions were quality improvement (QI) managers (48.5%), physicians (36.4%), or high-level administrators (27.3%). In clinics, champions were physicians (37.0%), QI managers (26.1%) or medical assistants (23.9%). Champions in both health systems and clinics were most often assigned the role (45.5% and 45.7%, respectively); yet clinic champions were more likely to naturally emerge than health system champions (26.1% vs. 15.2%). Among naturally emerging champions, 64.3% experienced zero turnover, more than for assigned champions. While champions in both groups received training, more champions in health systems reported being trained than those in clinics (75.8% vs 52.2%). No significant differences in EBIs implemented were observed between those clinics with and without a champion. Zero champion turnover was associated with great or very great leadership support (68.9%), program adaptation (60.7%) and organizational capacity (54.1%). Interviews found that champions' roles included advocating for CRC screening, providing technical assistance for EBI implementation, creating organizational policies for CRC screening, and overseeing QI. Interviewees reported a desire to address champion sustainability.

conclusionThese findings inform the use of program champions for clinic-based public health programs. Naturally emerging champions were more stable than those assigned the role.

Indexed as

Colorectal cancer screeningEvidence-based interventionsProgram championsSurvey research

Identifiers

PMID40731371
PMCPMC12309199

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.